They are all CRO enterprises, but there is not much difference in themselves. Welfare and prospect: Yao Ming Biology >; Wuxi pharmatech > medici.
WuXi PharmaTech (stock code: 603259.SH/2359.HK) provides all-round and integrated new drug research and development and production services for the global biomedical industry. Wuxi pharmatech is committed to promoting the research and development of new drugs and bringing breakthrough treatment solutions to patients by empowering global pharmaceutical, biotechnology and medical device enterprises.
Based on the principle of putting research first and taking customers as the center, Wuxi PharmaTech helps customers improve their R&D efficiency through cost-effective and efficient R&D services, covering the research and development and production of chemical drugs, research and development and production of cell and gene therapy, and testing of medical devices.
WuXi PharmaTech's empowerment platform is carrying R&D innovation projects of more than 5,200 partners in more than 30 countries around the world, and it is committed to bringing more new and good drugs to patients around the world, and realizing the vision of "making the world free from incurable diseases" at an early date.
Company/enterprise culture
Vision:
Become the highest, widest and deepest capacity and technology platform in the global medical and health industry, so that there are no difficult drugs and diseases.
Task:
Create and improve an open platform for capabilities and technologies, and provide individualized treatment and health management solutions.
Core values:
Honest and dedicated, * * * bitter * *; Do the right thing and do it well.
Code of conduct:
Customer first, integrity, Excellence, efficient implementation, cross-border cooperation, change and innovation.
The above contents refer to Baidu Encyclopedia-Wuxi PharmaTech New Drug Development Co., Ltd.